Evidence map›Paper›PMID 35821204›Full record

ArticleTranslational psychiatry2022

Time moderates the interplay between 5-HTTLPR and stress on depression risk: gene x environment interaction as a dynamic process.

Claudia Delli Colli, Marta Borgi, Silvia Poggini, Flavia Chiarotti, Francesca Cirulli, Brenda W J H Penninx, Francesco Benedetti, Benedetta Vai, Igor Branchi

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Biomarkers of stress resilience: A review.Neuroscience applied · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Claudia Delli Colli *Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.
Marta Borgi *Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.
Silvia Poggini *Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.
Flavia ChiarottiCenter for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.
Francesca CirulliCenter for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0001-9440-1873
Brenda W J H PenninxDepartment of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
Francesco BenedettiPsychiatry & Clinical Psychobiology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-4949-856X
Benedetta VaiPsychiatry & Clinical Psychobiology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Igor BranchiCenter for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy. igor.branchi@iss.it.ORCID 0000-0003-4484-3598
Istituto Superiore di Sanità · ITVita-Salute San Raffaele University · ITAmsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The serotonin-transporter-linked promoter region (5-HTTLPR) has been widely investigated as contributing to depression vulnerability. Nevertheless, empirical research provides wide contrasting findings regarding its involvement in the etiopathogenesis of the disorder. Our hypothesis was that such discrepancy can be explained considering time as moderating factor. We explored this hypothesis, exploiting a meta analytic approach. We searched PubMed, PsychoINFO, Scopus and EMBASE databases and 1096 studies were identified and screened, resulting in 22 studies to be included in the meta-analyses. The effect of the 5-HTTLPR x stress interaction on depression risk was found to be moderated by the following temporal factors: the duration of stress (i.e. chronic vs. acute) and the time interval between end of stress and assessment of depression (i.e. within 1 year vs. more than 1 year). When stratifying for the duration of stress, the effect of the 5-HTTLPR x stress interaction emerged only in the case of chronic stress, with a significant subgroup difference (p = 0.004). The stratification according to time interval revealed a significant interaction only for intervals within 1 year, though no difference between subgroups was found. The critical role of time interval clearly emerged when considering only chronic stress: a significant effect of the 5-HTTLPR and stress interaction was confirmed exclusively within 1 year and a significant subgroup difference was found (p = 0.01). These results show that the 5-HTTLPR x stress interaction is a dynamic process, producing different effects at different time points, and indirectly confirm that s-allele carriers are both at higher risk and more capable to recover from depression. Overall, these findings expand the current view of the interplay between 5-HTTLPR and stress adding the temporal dimension, that results in a three-way interaction: gene x environment x time.

Indexed as

Gene-Environment InteractionDepressionGenotypeRisk FactorsSerotonin Plasma Membrane Transport ProteinsStress, PsychologicalTime FactorsSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Identifiers

PMID35821204
PMCPMC9276704
OpenAlexW4285095578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.